Results 341 to 350 of about 8,254,551 (385)

ASSOCIAÇÃO DO POLIMORFISMO DO GENE LIGANTE DE MORTE PROGRAMADA-1 (PD-L1) COM O CÂNCER DE MAMA

Diego de Aragão Bezerra, Francisco das Chagas Medeiros, Janssen Loiola Melo Vasconcelos, Anderson Weiny Barbalho Silva, Ernando Igo Teixeira de Assis, Yuri Matos de Aragão Bezerra, Tárcilla Pinto Passos Bezerra, José Juvenal Linhares   +7 more
openalex   +2 more sources

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study. [PDF]

Cancer Med
Bønløkke S, Blaakær J, Steiniche T, Iachina M.   +3 more
europepmc   +1 more source

CONSENSO DE ESPECIALISTAS PARA ELABORAÇÃO E VALIDAÇÃO DE RECOMENDAÇÕES NUTRICIONAIS PROPORCIONAIS PARA CADA UM DOS GRAUS DE RISCO IDENTIFICADOS COM O USO DO ALGORITMO DE TRIAGEM NUTRICIONAL PARA PACIENTES COM CÂNCER INCURÁVEL EM CUIDADOS PALIATIVOS

openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Generalized structural equation modeling of demographic disparities in human papillomavirus (HPV) vaccine uptake among female schoolteachers in a middle eastern country. [PDF]

Infect Agent Cancer
Akhtar S, Rezqalla J, Alshatti M, Ibraheem A, Omar D, Al-Failakawi H, AlHaqqan S, AlGhurair S.   +7 more
europepmc   +1 more source

Quem brinca seus males espanta: estudo exploratório do brincar em crianças hospitalizadas com câncer

, 2009
Raquel Vasconcellos Van Boggelen
openalex   +1 more source

RASTREAMENTO DO CÂNCER DO COLO DO ÚTERO NO BRASIL: AVANÇOS, DESAFIOS E PERSPECTIVAS NA ATENÇÃO PRIMÁRIA

Daniel Magno Charone, ANA BEATRIZ ACIOLI FARIA, YASMIN CAVALLEIRO DE MACEDO MARANHÃO, MARIANA CALUFF CANTO, ANA LUIZA PESSOA SILVA   +4 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source